As we look toward 2023 and a sense of normalcy that has eluded us for the past few years, there are several big things on the horizon to keep an eye on in pharmacy, medication use and high-quality, value-based care.
Specialty pharmacy continues to be dynamic, demanding and disruptive, undergoing rapid and dramatic change.
Walgreens’ overarching strategy is built on a combination of health and wellness expertise and exceptional convenience, says senior vice president and chief merchandising officer Luke Rauch.
Last year I reported that the COVID-19 pandemic drove tremendous growth in demand for over-the-counter medicines for pain and fever, dietary supplements for immune support and wellness, and consumer medical devices for self-diagnosis and protection.
In recent decades, pharmacy benefit managers have grown into shadowy and hugely influential players in the prescription drug supply chain. For the most part, they have managed to avoid public scrutiny and government regulation.
As the COVID-19 pandemic enters its third year, the public health emergency (PHE) declaration that has underpinned the country’s COVID-19 response efforts by providing the federal government with emergency powers, regulatory flexibilities and additional resources is currently set to expire in early
This week’s Video Forum features two leaders of the newly minted Haleon.
It is easy for those who are not health care professionals to overlook the tremendous potential for innovation in our field today. Similarly, anyone who is not a health policy wonk might not see the important ways policy is evolving to improve the delivery of care for millions of patients.
The pharmacy profession and patient care services delivered by the pharmacy team have evolved significantly over the past few years, bringing new opportunities and challenges.
A contentious midterm election is behind us, and while pundits and other experts argue about what the results mean, those of us who deeply care about sound health care policy can hope for a new year where solid evidence and the quest for transparent information matters at least as much as political
New, exciting trends are emerging in community pharmacy practice, but what’s past is still prologue. Sal D’Angelo, a past president of the National Community Pharmacists Association/National Association of Retail Druggists, was the first person I heard say, “Get into politics or get out of pharmacy.
pharmaceutical and commercial — has become even more evident amid the COVID-19 pandemic. These are among the many reasons why today is both an exciting and challenging time to practice
As we welcome 2023 and the beginning of the 118th Congress, HDA pharmaceutical distributor members’ role as a convener within the health care ecosystem will be more important than ever.
The future of health care in this country will center on ecosystems that span the continuum of care. A number of entities, including companies with roots in chain pharmacy, are in the process of altering their business model to align with the new paradigm. None of them is further along in assembling
An article by McKinsey & Co. describes the current era with the words: “Return, Reimagine, Reinvent.” I cannot think of better positioning for our industry and for NACDS specifically in the association’s 90th Anniversary year. Our industry can look at the word “Return” from two angles.
No one knows for certain what the new year will bring for chain pharmacy operators.
